NFE2/Nrf2 repression
2017-06-02T16:27:16
2017-06-02T16:27:16
NFE2/Nrf2 repression
NFE2/Nrf2 repression
Molecular
2017-06-02T16:27:39
2017-06-02T16:27:39
Increased, steatosis
Increased, steatosis
Organ
2017-06-02T16:28:19
2017-06-02T16:28:19
Reduced, FXR activity
Reduced, FXR activity
Molecular
2017-06-02T16:29:13
2017-06-02T16:29:13
Reduced, SHP activity
Reduced, SHP activity
Molecular
2017-06-02T16:30:54
2017-06-02T16:30:54
Activated, LXR
Activated, LXR
Molecular
2017-06-02T16:31:25
2017-06-02T16:31:25
Reduced, PPARalpha
Reduced, PPARalpha
Molecular
2017-06-02T16:32:03
2017-06-02T16:32:03
Reduced, HSD17B4 activity
Reduced, HSD17B4 activity
Molecular
2017-06-02T16:32:45
2017-06-02T16:32:45
Reduced, fatty acid beta oxidation
Reduced, fatty acid beta oxidation
Molecular
2017-06-02T16:35:30
2017-06-02T16:35:30
4cc00bf8-14ee-44b6-9b5f-669b1bef04bb
8ef8d6d7-166a-45e4-86a1-572438a737ed
2017-06-02T16:35:50
2017-06-02T16:35:50
8ef8d6d7-166a-45e4-86a1-572438a737ed
7859b7fe-76f6-4a78-ad80-410a8169730a
2017-06-02T16:36:04
2017-06-02T16:36:04
7859b7fe-76f6-4a78-ad80-410a8169730a
d6e50856-701d-4c73-83cf-a015103f68f2
2017-06-02T16:36:22
2017-06-02T16:36:22
d6e50856-701d-4c73-83cf-a015103f68f2
ec209a46-4a79-4a6e-a9e4-62ed6fec6431
2017-06-02T16:36:37
2017-06-02T16:36:37
ec209a46-4a79-4a6e-a9e4-62ed6fec6431
d99ea751-a3a4-4f98-99c2-b8798bef05ce
2017-06-02T16:36:51
2017-06-02T16:36:51
d99ea751-a3a4-4f98-99c2-b8798bef05ce
4161221e-fe8e-427a-b018-abc9981d797e
2017-06-02T16:37:13
2017-06-02T16:37:13
4161221e-fe8e-427a-b018-abc9981d797e
418c27de-14be-4c97-a433-7aa93e5a132c
2017-06-02T16:37:26
2017-06-02T16:37:26
NFE2/Nrf2 repression to steatosis
NFE2/Nrf2 repression to steatosis
Open for adoption
Under Development
adjacent
Not Specified
Not Specified
adjacent
Not Specified
Not Specified
adjacent
Not Specified
Not Specified
adjacent
Not Specified
Not Specified
adjacent
Not Specified
Not Specified
adjacent
Not Specified
Not Specified
adjacent
Not Specified
Not Specified
Not Specified
2017-06-02T16:26:43
2023-04-29T16:03:00